S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management (2015/2/3)|
|Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases (2015/1/7)|
|Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension (2015/1/12)|
|Arena Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference (2015/2/2)|
|Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Monday, March 2 (2015/2/23)|
|Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference (2015/2/18)|
|Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference (2015/1/6)|
|Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV (2015/1/9)|
|Arena Pharmaceuticals Announces Agreement to Sell Common Stock (2015/1/21)|
|Arena Pharmaceuticals Announces Public Offering of Common Stock (2015/1/20)|
Click above to view more mutual fund data and stats for arna - Arena Pharmaceuticals Inc.